Revised US industry code bans entertainment and gifts
This article was originally published in RAJ Devices
Executive Summary
US medtech industry association AdvaMed says it has made major revisions to its code of ethics on interactions with healthcare professionals that further “clarify and distinguish between” appropriate and inappropriate activity between healthcare professionals and representatives of AdvaMed member companies1. The revised code, which takes effect on 1 July 2009, explicitly prohibits companies from providing entertainment or recreation to healthcare professionals and prohibits gifts of any type, including all non-educational branded promotional items, regardless of value.
You may also be interested in...
EU Accelerated Assessment Tracker
Marinus’s ganaxolone has lost its accelerated assessment status mid-review at the European Medicines Agency while Roche’s glofitamab will be fast-tracked once a filing has been made.
EU Accelerated Assessment Tracker
The EU filing for AstraZeneca’s nirsevimab is being reviewed under the accelerated pathway at the European Medicines Agency. Also, Janssen should know by now whether its planned filing for Zejula plus Zytiga will get the same treatment – as should SIFI for its planned Akantior filing.
AZ Secures EU Fast-Tack Review For Nirsevimab
There could be a regulatory decision on AstraZeneca and Sanofi's nirsevimab in the EU in H2 as a result of the European Medicines Agency speeding up its review of the marketing application for the potential new immunization against RSV in all infants.